• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXHB2100057 泽布替尼胶囊 zanubrutinib Capsule Chemical Drugs(原1.1) Supplementary Application 2021-04-10 百济神州(北京)生物科技有限公司 BeiGene (Beijing) Co Ltd In Review 2022-01-27 view
JXSS2100020 注射用贝林妥欧单抗 blinatumomab Lyophilized Biological Products(3.1) Import Drug Application 2021-03-31 百济神州(北京)生物科技有限公司 BeiGene (Beijing) Co Ltd In Review 2021-03-30 view
JYSB2100061 注射用贝林妥欧单抗 blinatumomab Lyophilized Biological Products(3.1) Supplementary Application 2021-02-26 百济神州(北京)生物科技有限公司 BeiGene (Beijing) Co Ltd In Review 2022-01-27 view
JXHB2100022 AMG 510 SOTORASIB Active ingredient Chemical Drugs(1) Supplementary Application 2021-02-21 百济神州(北京)生物科技有限公司 BeiGene (Beijing) Co Ltd In Review 2021-02-20 view
JXSS2100004 注射用司妥昔单抗 siltuximab Lyophilized Biological Products(3.1) Import Drug Application 2021-01-20 百济神州(北京)生物科技有限公司 BeiGene (Beijing) Co Ltd Certificate Issued 2021-12-06 view
JXSS2100005 注射用司妥昔单抗 siltuximab Lyophilized Biological Products(3.1) Import Drug Application 2021-01-20 百济神州(北京)生物科技有限公司 BeiGene (Beijing) Co Ltd Certificate Issued 2021-12-06 view
CXHB2100005 泽布替尼胶囊 zanubrutinib Capsule Chemical Drugs(1) Supplementary Application 2021-01-09 百济神州(北京)生物科技有限公司 BeiGene (Beijing) Co Ltd In Review 2021-01-08 view
JXSS2000048 迪妥昔单抗注射液 dinutuximab Injection Biological Products(3.1) Import Drug Application 2020-11-04 百济神州(北京)生物科技有限公司 BeiGene (Beijing) Co Ltd Certificate Issued 2021-08-17 view
JXSL2000195 AMG160 acapatamab Injection Biological Products(1) Import Drug Application 2020-11-02 百济神州(北京)生物科技有限公司 BeiGene (Beijing) Co Ltd In Review 2020-10-30 view
JXHB2000044 注射用卡非佐米 Carfilzomib Lyophilized Chemical Drugs(5.1) Supplementary Application 2020-11-02 百济神州(北京)生物科技有限公司 BeiGene (Beijing) Co Ltd In Review 2020-10-30 view
JXSL2000163 注射用ZW25 zanidatamab Lyophilized Biological Products(1) Import Drug Application 2020-09-29 百济神州(北京)生物科技有限公司 BeiGene (Beijing) Co Ltd In Review 2020-09-28 view
JXHB2000033 AMG 510 SOTORASIB Active ingredient Chemical Drugs(1) Supplementary Application 2020-09-25 百济神州(北京)生物科技有限公司 BeiGene (Beijing) Co Ltd In Review 2020-09-24 view
CXHB2000095 帕米帕利胶囊 pamiparib Capsule Chemical Drugs(1) Supplementary Application 2020-09-23 百济神州(北京)生物科技有限公司 BeiGene (Beijing) Co Ltd In Review 2020-09-22 view
JXSL2000150 注射用ZW25 zanidatamab Lyophilized Biological Products(1) Import Drug Application 2020-09-10 百济神州(北京)生物科技有限公司 BeiGene (Beijing) Co Ltd In Review 2020-09-09 view
JXHL2000231 AMG 650 sovilnesib Active ingredient Chemical Drugs(1) Import Drug Application 2020-08-21 百济神州(北京)生物科技有限公司 BeiGene (Beijing) Co Ltd In Review 2020-08-19 view
JXSB2000007 AMG160 acapatamab Injection Biological Products Supplementary Application 2020-08-21 百济神州(北京)生物科技有限公司 BeiGene (Beijing) Co Ltd In Review 2020-08-19 view
JXHL2000232 AMG 650 sovilnesib Active ingredient Chemical Drugs(1) Import Drug Application 2020-08-21 百济神州(北京)生物科技有限公司 BeiGene (Beijing) Co Ltd In Review 2020-08-19 view
CXHB2000072 泽布替尼胶囊 zanubrutinib Capsule Chemical Drugs(原1.1) Supplementary Application 2020-08-20 百济神州(北京)生物科技有限公司 BeiGene (Beijing) Co Ltd In Review 2020-08-19 view
JXHL2000206 AMG 510 SOTORASIB Active ingredient Chemical Drugs(1) Import Drug Application 2020-07-08 百济神州(北京)生物科技有限公司 BeiGene (Beijing) Co Ltd In Review 2020-07-07 view
JXSL2000100 AMG 910 AMG 910 Injection Biological Products Import Drug Application 2020-07-01 百济神州(北京)生物科技有限公司 BeiGene (Beijing) Co Ltd In Review 2020-06-29 view